BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33541631)

  • 1. Inhibition of growth and metastasis of breast cancer by targeted delivery of 17-hydroxy-jolkinolide B via hyaluronic acid-coated liposomes.
    Liu D; Zhang Q; Wang J; Guan S; Cai D; Liu J
    Carbohydr Polym; 2021 Apr; 257():117572. PubMed ID: 33541631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
    Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
    Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer.
    Sun Y; Li X; Zhang L; Liu X; Jiang B; Long Z; Jiang Y
    Mol Pharm; 2019 Mar; 16(3):1140-1155. PubMed ID: 30668131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamic evaluation of hyaluronic acid-modified imatinib-loaded PEGylated liposomes in CD44-positive Gist882 tumor-bearing mice.
    Huang J; Chen J
    J Liposome Res; 2024 Mar; 34(1):97-112. PubMed ID: 37401372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer.
    Liu D; Zhang Q; Wang J; Fan L; Zhu W; Cai D
    Pharmazie; 2019 Feb; 74(2):83-90. PubMed ID: 30782256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
    Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
    Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
    Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
    J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Delivery of Hesperetin and Cisplatin via Hyaluronic Acid-Modified Liposome for Targeted Inhibition of Aggression and Metastasis of Triple-Negative Breast Cancer.
    Wang X; Song Y; Yu L; Xue X; Pang M; Li Y; Luo X; Hua Z; Lu C; Lu A; Liu Y
    ACS Appl Mater Interfaces; 2023 Jul; 15(29):34360-34377. PubMed ID: 37432741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model.
    Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M
    Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tunable conjugation densities of camptothecin on hyaluronic acid for tumor targeting and reduction-triggered release.
    Chen Z; He N; Chen M; Zhao L; Li X
    Acta Biomater; 2016 Oct; 43():195-207. PubMed ID: 27424081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs.
    Liu J; Zhang D; Lian S; Zheng J; Li B; Li T; Jia L
    Int J Nanomedicine; 2018; 13():7457-7472. PubMed ID: 30532533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
    Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma.
    Deng C; Zhang Q; Fu Y; Sun X; Gong T; Zhang Z
    ACS Appl Mater Interfaces; 2017 Jan; 9(2):1280-1292. PubMed ID: 28009503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
    Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
    ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial targeted hierarchical drug delivery system based on HA-modified liposomes for cancer therapy.
    Chen H; Fang Z; Song M; Liu K
    Eur J Med Chem; 2022 Nov; 241():114648. PubMed ID: 35963128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.